Forge an innovative path towards a cure by tapping into our decades of experience in delivering gene therapy solutions that can help you navigate obstacles and challenges. Our end-to-end solutions, high quality products and unrivaled services are here to support you at every step of the way, from gene therapy research to gene therapy commercialization.

 

Gene Therapy Brochure

Producing safe, effective, and reproducible gene therapies can be more complicated than meets the eye. Success within this complex space requires a partner with knowledge and connections to help you overcome obstacles and accelerate your research and therapeutic production processes.   Download our brochure to learn more about our end-to-end gene therapy workflow solutions.

Download

 
Adeno-associated viruses as part of gene therapy manufacturing process

Scalable AAV vector manufacturing

Connect to the innovative solutions designed to accelerate your AAV-based therapy projects and optimize your AAV vector development and manufacturing workflows. We offer solutions and expertise ranging from plasmid development and production to fill and finish options.

AAV Production Workflow

Scalable lentiviral vector manufacturing

Accelerate the development of your gene-modified cell therapies and gene therapies by connecting to solutions that span your entire lentivirus workflow. From superior products and services to expertise for every phase, explore the solutions that help you develop breakthrough lentivirus gene therapies.

LV Production Workflow

Lentivirus particles as part of gene therapy manufacturing process
CDMO viral vector manufacturing solutions

CDMO solutions for cGMP viral vector production

Our deep technical and analytical expertise helps ensure quality and compliance while operating with transparency and flexibility. Connect to a viral vector CDMO partner with over 20 years of experience developing processes and producing cGMP viral vectors.

See our viral vector production capabilities

Nucleic acid therapeutics development

Our range of high-quality raw materials are designed to optimize your oligonucleotide and mRNA synthesis, helping you progress from development to manufacturing and commercialization. Connect to a partner that will help you reach your nucleic acid therapeutics development goals.

Explore our Nucleic Acid Therapeutic Development Systems

Gene therapy development scientist in full PPE
Scientist conducting documentation is support of gene therapy research

Gene therapy manufacturing solutions

Our goal is to support you at every stage of your development process, connecting you to gene therapy manufacturing solutions. We can provide regulatory support and documentation, custom gene therapy products and services and scale-up assistance to help you reach your gene therapy goals.

Explore our custom gene therapy manufacturing solutions

Contaminant and impurity QC testing

Find out how we can connect you to the latest, cutting-edge technology that helps ensure quality, safety and accuracy to meet your in-process and lot release testing needs.

Contaminant and Impurity QC Testing

Scientist removing tubes from centrifuge in a gene therapy research lab
Gene therapy vials being pulled from -80C freezer in support of gene therapy commercialization

Global clinical trial services and supply chain solutions

Protect your irreplaceable gene therapy materials by connecting to expert advice and optimized solutions for transporting, storing, and handling specialized biological samples and material, from ambient to ultra-low temperatures.

Explore our Gene Therapy Supply Chain Capabilities

Connect to innovations in gene therapy development

POROS CaptureSelect AAVX Affinity Resin

POROS CaptureSelect AAVX Affinity Resin
 

POROS CaptureSelect AAVX Affinity Resin is engineered to address the high selectivity and capacity requirements for large-scale downstream purification of a broad range of naturally occurring and synthetic adeno-associated virus (AAV) serotypes used for gene therapy applications. It has demonstrated binding reactivity towards a set of AAV serotypes that includes AAV1 to AAV8, and AAVrh10 as well as synthetic serotypes.

Learn more